Back
Altimmune Stock Predictions
Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
15
ALT
Altimmune
Last Price:
$4.30
Seasonality Move:
1.93%
7 Day Trial
ALL ACCESS PASS
$
7
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Altimmune Stock Forecast
Will Altimmune Stock Go Up Next Year?
Data Unavailable
Altimmune Stock Rating
Data Unavailable
Altimmune Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
altimmune.com
52-Week Data
52-Week High:
11.16
52-Week Low:
3.55
Prediction Charts
Market Cap:
320.4M
Price in USD:
4.16
Volume:
2.1M
Beta:
1.20
Technical Analysis
SMA50:
5.83
SMA100:
6.90
SMA200:
6.82
52-Wk Change:
-48.06%
Stock Predictions
-
Is Altimmune stock public?Yes, Altimmune is a publicly traded company.
-
What is the Altimmune stock quote today?The Altimmune stock price is 4.16 USD today.
-
How to buy Altimmune stock online?You can buy Altimmune shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-24 | 5.84 | 6.05 | 6.16 | 5.82 |
| Mar-25 | 6.01 | 5.89 | 6.04 | 5.84 |
| Mar-26 | 5.86 | 5.59 | 5.92 | 5.56 |
| Mar-27 | 5.58 | 5.57 | 5.63 | 5.45 |
| Mar-28 | 5.57 | 5.32 | 5.57 | 5.30 |
| Mar-31 | 5.07 | 5.00 | 5.12 | 4.78 |
| Apr-1 | 4.95 | 4.75 | 5.13 | 4.70 |
| Apr-2 | 4.67 | 4.78 | 4.96 | 4.65 |
| Apr-3 | 4.48 | 4.46 | 4.73 | 4.43 |
| Apr-4 | 4.30 | 4.24 | 4.44 | 4.13 |
| Apr-7 | 4.00 | 3.98 | 4.22 | 3.75 |
| Apr-8 | 4.12 | 3.67 | 4.21 | 3.55 |
| Apr-9 | 3.60 | 4.23 | 4.47 | 3.60 |
| Apr-10 | 4.21 | 4.16 | 4.28 | 3.93 |
Altimmune Earnings
Data Unavailable
Altimmune Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.26 per share, and a decrease next year of $0.52 per share.
* Altimmune stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.